Bristol-Myers Squibb Stock: A Strong Buy Amid Oncology Success
Bristol-Myers Squibb released financial results for Q4 2024. Check out why I am upgrading BMY stock's rating from 'Buy' to ...
Bristol Myers Squibb GC to Retire After 33 years With Drugmaker
Sandra Leung began her legal career prosecuting homicides, a formative experience that she once said taught her "to make ...
Bristol-Myers Squibb (BMY) Receives a Buy from Truist Financial
Truist Financial analyst Srikripa Devarakonda maintained a Buy rating on Bristol-Myers Squibb (BMY – Research Report) today. The company’s ...
Bristol Myers Squibb Names New GC as Legal Chief Retires
Bristol Myers Squibb Co. said Cari Gallman, the company’s executive vice president for corporate affairs, will become its ...
Treasury2d
Bristol Myers Squibb Lights the Way to Treasury Innovation
For the Bristol Myers Squibb (BMS) treasury function, innovation has long been fundamental. Still, after integrating with ...
pharmaphorum2d
A history of Bristol-Myers Squibb
Bristol-Myers Squibb was founded in 1858 and has grown to be one of today's leading global pharmaceutical companies. For over 150 years, Bristol-Myers Squibb (BMS) has been committed to "discover ...
Why Bristol-Myers Squibb (BMY) Is Among the Best Drug Stocks to Buy Now
We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where ...
Morningstar4d
Bristol-Myers Squibb Co
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Hosted on MSN6d
Compugen Updates Filing Structure with Bristol Myers Squibb
Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio The latest announcement is out from Compugen ( (CGEN)). Compugen, a foreign private ...